Optalysys has created a new video showing the co-processor system being developed for genome alignment. This product will be available at the end of 2017. The video describes the key features of the product and its initial application within bioinformatics as well as other areas optical processing technology is or could be applied to.
Optalysys was founded in 2013. CEO Dr Nick New, a renowned world expert in optical pattern recognition, developed the forerunner to the Optalysys technology whilst carrying out his PhD on optical pattern recognition at Cambridge University. Dr New went on to forge relationships with international academic and commercial institutions before securing funding to take Optalysys forward.
The Optalysys team includes specialists in software development, Computational Fluid Dynamics (CFD), free-space optics, optical engineering and production engineering.
The company has several patents covering its groundbreaking technology.